A randomized placebo-controlled PET study of ketamine´s effect on serotonin 1B receptor binding in patients with SSRI-resistant depression
Saved in:
Tiger, M., et al., A randomized placebo-controlled PET study of ketamine´s effect on serotonin 1B receptor binding in patients with SSRI-resistant depression. Transnational Psychiatry, n. 10, 2020, 8 p.
Ref.
552500
Location:
SIIS Archivo
Palabras clave:
Drogodependencias, Fármacos, Efectos, Beneficios, Depresión, Enfermedades mentales, Cerebro
Drogodependencias, Fármacos, Efectos, Beneficios, Depresión, Enfermedades mentales, Cerebro
Similar Items: A randomized placebo-controlled PET study of ketamine´s effect on serotonin 1B receptor binding in patients with SSRI-resistant depression
- Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
- INHALED DRUGS OF ABUSE ENHANCE SEROTONIN-3 RECEPTOR FUNCTION
- CHRONIC EXPOSURE TO MORPHINE, COCAINE OR ETHANOL IN RATS PRODUCED DIFFERENT EFFECTS IN BRAIN CANNABIOID CB RECEPTOR BINDING AND MRNA LEVELS
- Endogenous positive allosteric modulation of GABA receptors by Diazepam binding inhibitor
- La PET muestra los cambios cerebrales de adictos a drogas
- TREATMENT OF ALCOHOLIC ORGANIC BRAIN SYNDROME WITH THE SEROTONIN REUPTAKE INHIBITOR FLUVOXAMINE: A PRELIMINARY STUDY